Finance

Lists
Q3 2026 earnings • in 4 days
See details
OSUR:NASDAQ
OraSure Technologies Inc
$3.72
+5.38%
(+0.19) 1D
$3.72
0.00% (0.00)
After hours
Closed: Nov 4, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OSUR...
Open
$3.56
High
$3.76
Low
$3.56
Mkt. cap
256.56M
Avg. vol.
613.21K
Volume
0.00
52-wk high
$4.58
52-wk low
$2.08
EPS
-$0.69
Beta
1.08
Shares outstanding
68.97M
No. of employees
500
Open
$3.56
High
$3.76
Low
$3.56
Mkt. cap
256.56M
Avg. vol.
613.21K
Volume
0.00
52-wk high
$4.58
52-wk low
$2.08
EPS
-$0.69
Beta
1.08
Shares outstanding
68.97M
No. of employees
500
News stories
From web sources and news partners
Profile
OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test. Wikipedia
About OraSure Technologies Inc
CEOCarrie Eglinton Manner
Employees500
FoundedDec 11, 1987
HeadquartersBethlehem, Pennsylvania, United States
SectorMedical device
Industry-
Websiteorasure.com
Analyst ratings
Based on 1 analyst giving stock ratings to OSUR in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for OSUR in the last 3 months
Highest
Current $3.72
$7.00 (+88.17%)
Average
$7.00 (+88.17%)
Lowest
$7.00 (+88.17%)
Analyst
Recommendation
Action
Price target
Projected
Date
William Bonello
Craig-Hallum
Buy
Initiated
$7.00
+88.2%
10/23/2026
Next call in 4 days
Tue, Nov 10, 12:00 AM
Fiscal period
Q3 2026
- / -$0.18
Revenue / Est. (USD)
- / 31.02M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
27.08M
26.76M
27.92M
30.64M
Cost of goods sold
15.31M
15.80M
16.06M
17.32M
Cost of revenue
15.31M
15.80M
16.06M
17.32M
Research and development expenses
10.11M
11.42M
13.39M
9.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.38M
15.90M
20.39M
21.03M
Operating expense
27.49M
27.32M
33.78M
30.47M
Total operating expenses
42.80M
43.12M
49.83M
47.79M
Operating income
-15.71M
-16.35M
-21.91M
-17.15M
Other non operating income
2.20M
1.87M
128.00K
272.00K
EBT including unusual items
-13.66M
-19.08M
-22.81M
6.30M
EBT excluding unusual items
-13.29M
-15.32M
-21.45M
-16.29M
Income tax expense
47.00K
210.00K
-432.00K
55.00K
Effective tax rate
-0.34%
-1.10%
1.89%
0.87%
Other operating expenses
-
-
-
-
Net income
-13.71M
-19.29M
-22.38M
6.25M
Net profit margin
-50.63%
-72.06%
-80.13%
20.40%
Earnings per share
-0.13
-0.19
-0.24
-0.20
Interest and investment income
-
-
1.22M
1.20M
Interest expense
-
-
-
-
Net interest expenses
-
-
1.22M
1.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.26M
-13.95M
-19.57M
-14.78M
Gain or loss from assets sale
-213.00K
268.00K
-
-20.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps